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a b s t r a c t
Carcinoids represent 1–2% of the rectal cancer. We report the case of a woman with a rectal carcinoid
and a hypogastric node metastasis. We propose a less invasive treatment of the metastase using In11-
octreotide-scintigraphy and intraoperative gamma-probe detector.
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. Introduction
Carcinoid tumors are included in the Apudoma category. They
epresent 1–2% of cancers of the rectum. These tumors may
e asymptomatic and they are accidentally diagnosed during
ndoscopy screening. Proctorrhagia is the most common clini-
al manifestation.1 Most neuroendocrine tumors (NET) express
eceptors for somatostatin (SS), and thus can be successfully
etected using radiolabeled antibodies against the SS receptor.
ome tumors of neuroectodermal origin express receptors for SS,
nd they are detectable by SRS (somatostatin receptor scintig-
aphy), among these are carcinoid, medullary thyroid cancer,
aragangliomas and neuroblastomas.2 The main study published
y Krenning et al. (1993) and other experience have validated
he SRS with 111Indium-DTPA-octreotide as a standard imaging
echnique for neuroendocrine tumors.3 Many studies have shown
hat SRS is more sensitive than conventional methods for identi-
ying metastases.4 The radio-guided surgery with gamma-probe
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Open access under CC BY-NC-ND lichas proved useful in the management of neuroendocrine tumors,
particularly with regard to the inguinal-femoral metastases.
2. Case presentation
A 49-year-old asymptomatic woman underwent colonoscopy
for proctorrhagia. Blood tests were normal, the patient having
only mild and nonspeciﬁc lymphocytosis. Endoscopic examina-
tion of the distal rectum demonstrated a sessile polyp of about
15mm in diameter. It was removed by diathermy loop. Histolog-
ical examination described the lesion as carcinoid, the structure
was partly classical and partly glandular, inﬁltrating the submu-
cosa. TheKi67 positivitywas 1–2%. Near themargin of resection the
histological examination demonstrated low-grade carcinoid cells.
We adopted a close surveillance policy. After two months we per-
formed a colonoscopy with biopsies in the polypectomy area that
came back negative. CT was performed after 3 months and MRI
and US were performed after 6 months for staging. All showed
the absence of recurrence. In line with international protocols for
staging carcinoids a 111In-octretide (OctreoscanTM) was also car-
ried out 6 months postoperatively. This documented an outbreak
of hyperﬁxation in the left pelvic region (iliac fossa) at the iliac-
hypogastric lymph node chain, a ﬁnding suggestive of the presence
of lymph node localization expressing somatostatin receptors and
therefore, worthy for further investigation. The results of a SRS
after 3 months were similar to the previous ones, so we opted for
ense.
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urgical treatment. Five hundred MBq of 111In-octeoscanTM were
dministered 16h before the procedure. A Leriche incision was
erformed, exposing the iliac obturator hypogastric region. After
areful exploration with the probe for radioguided surgery (with
indow adequate to Indium emission), a small hard lymph node
as located behind the hypogastric vessels. It was characterized
y signal-to-background ratio of 7:1. After the node removal the
ackground activity in the iliac-hypogastric region remained equal
o the contralateral side. Histological examination of the surgical
pecimen conﬁrmed lymphnode localization ofwell-differentiated
ndocrine tumor, compatible with carcinoid.
. Discussion
Surgical resection of primary tumor and lymphnodemetastases
s the only curative method for carcinoids. Recently, endoscopic
reatment was applied for carcinoids of the gastrointestinal tract.
electing the most appropriate treatment requires a precise char-
cterization in terms of localization and deﬁnition of size, depth
f invasion and histological type. It also requires adequate stag-
ng. Rectal carcinoids less than 10mm in diameter contained in the
ubmucosa without evidence of lymphatic metastases are endo-
copically resectable.5 As for carcinoids between 10 and 15mm,
he therapeutic strategy remains controversial.6
The present polyp was 15mm, thus within the range limits in
hich endoscopic removal can be performed. In agreement with
he case studies by Lamberts et al.,7 87% of carcinoids express
omatostatin receptors, and this is why they can be detected with
emarkable sensitivity by SRS with Indium111-octreotide. It is cur-
ently established that this method is more sensitive than CT or
ltrasound for diagnosis, staging and follow-up.7,8 Using the probe
or radioguided surgery, intraoperatively after administration of
ndium111-octreotide, is more sensitive than using SRS or intra-
perative palpation, therefore it allows a more radical surgery.9–13
owever, we have to point out that this procedure can be quite
omplicated since, the probe detects a relatively large amount of
ackground due to nearby structures (mainly small bowel) which
ay retain the radioactive tracer. The problem can be partly solved
ith a careful study of visualization times of both the lesion and the
ntestine at the time of SRS diagnostics. The advantage of using the
robeduring the surgical removal of lymphnodesmetastasis is that
t ensures a radical surgery without performing an extended resec-
ion procedure, as in our case it would have been the full removal
f illo-hypogastric lymph node.. Conclusions
In cases of small rectal carcinoids, it is important to perform
RS-Indio111-octreotide before surgery to determine the extent
f ﬁxation of the tracer and the presence of metastases, even ifurgery Case Reports 2 (2011) 49–50
CT, MRI and endoscopic ultrasonography are negative. The SRS is
also strongly recommended for follow-up. The main point of inter-
est is the use of radioguided surgery in selected cases, which can
allow a radical intervention in cases of lymph node metastases,
while performing a less extended and/or aggressive procedure than
the exploration of the entire neighboring lympho-adipose tissue. It
should be noted that the method has some technical difﬁculties
related to the background noise. This makes the identiﬁcation of
the peak of radioactivity more challenging, and requires a careful
exploration of the region of interest.
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